Abhishek Srivastava
Keine laufenden Positionen mehr
Vermögen: 93 $ am 30.04.2024
Karriereverlauf von Abhishek Srivastava
Ehemalige bekannte Positionen von Abhishek Srivastava
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ALAUNOS THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 04.08.2022 | 01.10.2023 |
| ATHENEXPAR | Corporate Officer/Principal | - | - |
Ausbildung von Abhishek Srivastava
| University of Louisville School of Medicine | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 4 |
Operativ
| Chief Tech/Sci/R&D Officer | 1 |
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ALAUNOS THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Athenex, Inc.
 Athenex, Inc. Pharmaceuticals: MajorHealth Technology Athenex, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapies for the treatment of cancer. It operates through the Oncology Innovation Platform and Commercial Platform segments. The Oncology Innovation Platform segment focuses on the research and development of proprietary drugs. The Commercial Platform segment covers the sale and market of specialty drugs and market development of proprietary drugs. The company was founded by Lyn M. Dyster and David G. Hangauer in November 2003 and is headquartered in Buffalo, NY. | Health Technology |
- Börse
- Insiders
- Abhishek Srivastava
- Erfahrung
